Great West Life Assurance CO Madrigal Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 2,334 shares of MDGL stock, worth $762,727. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,334
Previous 1,289
81.07%
Holding current value
$762,727
Previous $274,000
162.41%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MDGL
# of Institutions
342Shares Held
22.3MCall Options Held
960KPut Options Held
936K-
Janus Henderson Group PLC London, X02.21MShares$722 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$667 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$663 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$652 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$645 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.59B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...